Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21434 | 360 | 30.3 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
88 | 25697 | ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LEUKOCYTAPHERESIS | Author keyword | 104 | 73% | 22% | 79 |
2 | ADACOLUMN | Author keyword | 42 | 94% | 4% | 15 |
3 | GRANULOCYTE AND MONOCYTE ADSORPTION APHERESIS | Author keyword | 38 | 93% | 4% | 14 |
4 | GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS | Author keyword | 22 | 81% | 4% | 13 |
5 | GRANULOCYTE MONOCYTE APHERESIS | Author keyword | 20 | 100% | 3% | 9 |
6 | GRANULOCYTAPHERESIS | Author keyword | 17 | 70% | 4% | 14 |
7 | GRANULOCYTE AND MONOCYTE APHERESIS | Author keyword | 14 | 100% | 2% | 7 |
8 | ADSORPTIVE APHERESIS | Author keyword | 13 | 80% | 2% | 8 |
9 | ADSORPTIVE GRANULOCYTE AND MONOCYTE APHERESIS | Author keyword | 8 | 100% | 1% | 5 |
10 | CELLSORBA | Author keyword | 8 | 100% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARRIER BASED GRANULOCYTE | 90 | 83% | 14% | 50 |
2 | MONOCYTE ADSORPTION APHERESIS | 64 | 73% | 14% | 49 |
3 | STEROID NAIVE PATIENTS | 51 | 91% | 6% | 21 |
4 | LEUKOCYTE REMOVAL FILTER | 44 | 78% | 8% | 29 |
5 | LEUKOCYTAPHERESIS | 41 | 63% | 11% | 41 |
6 | ADACOLUMN | 32 | 88% | 4% | 15 |
7 | ADSORPTION APHERESIS | 31 | 92% | 3% | 12 |
8 | INTENSIVE GRANULOCYTE | 31 | 92% | 3% | 12 |
9 | SELECTIVE LEUKOCYTAPHERESIS | 29 | 88% | 4% | 14 |
10 | SELECTIVE GRANULOCYTE | 27 | 78% | 5% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review | 2011 | 28 | 61 | 64% |
Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis | 2010 | 15 | 26 | 54% |
Selective leukocyte apheresis for the treatment of inflammatory bowel disease | 2007 | 19 | 65 | 54% |
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column | 2003 | 121 | 17 | 29% |
Leukocytapheresis for the treatment of IBD | 2008 | 6 | 45 | 84% |
Cytapheresis in inflammatory bowel diseases: Current evidence and perspectives | 2008 | 4 | 47 | 94% |
Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease | 2012 | 2 | 45 | 56% |
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action | 2009 | 7 | 47 | 60% |
The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease | 2006 | 26 | 78 | 40% |
Cytapheresis as a non-pharmacological therapy for inflammatory bowel disease | 2008 | 2 | 34 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LOWER GASTROENTEROL | 5 | 22% | 5.3% | 19 |
2 | GASTROENTEROL INFLAMMATORY BOWEL DIS | 2 | 31% | 1.4% | 5 |
3 | UPPER GASTROENTEROL | 2 | 12% | 3.6% | 13 |
4 | ADV IBD TREATMENT | 1 | 27% | 0.8% | 3 |
5 | UO IMMUNOEMATOL | 1 | 23% | 0.8% | 3 |
6 | BLOOD PURIFICAT BUSINESS UNIT | 1 | 50% | 0.3% | 1 |
7 | CELL TISSUE ENGI | 1 | 50% | 0.3% | 1 |
8 | CHILDRENS HOSP HUDDINGE | 1 | 50% | 0.3% | 1 |
9 | GASTROENTEROL IBD | 1 | 50% | 0.3% | 1 |
10 | JIMRO | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000274946 | SEVERE ULCERATIVE COLITIS//TOXIC MEGACOLON//STEROID REFRACTORY ULCERATIVE COLITIS |
2 | 0.0000094490 | MESALAZINE//5 AMINOSALICYLIC ACID//MESALAMINE |
3 | 0.0000088274 | INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB |
4 | 0.0000081103 | DEXTRAN SULFATE SODIUM//EXPERIMENTAL COLITIS//BIOL CHEM BIOACT |
5 | 0.0000076871 | INTESTINAL EPITHELIAL//CRI 4U004B//LUMINAL CYTOKINES |
6 | 0.0000070766 | FECAL CALPROTECTIN//CALPROTECTIN//FECAL ALPHA 1 ANTITRYPSIN |
7 | 0.0000056879 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |
8 | 0.0000055970 | THORACIC DUCT DRAINAGE//CD4 SUPPRESSOR T CELL//GUSPERIMUS HYDROCHLORIDE |
9 | 0.0000052085 | EXTRACORPOREAL PHOTOCHEMOTHERAPY//PHOTOPHERESIS//EXTRACORPOREAL PHOTOPHERESIS |
10 | 0.0000051034 | MONOCYTE SUBSETS//MONOCYTE HETEROGENEITY//MONOCYTE SUBSET |